APA (7th ed.) Citation

Labban, M., Izmirlieva, M., & Ando, G. (2013). Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates. Value in Health, 16(7), A455. https://doi.org/10.1016/j.jval.2013.08.764

Chicago Style (17th ed.) Citation

Labban, M., M. Izmirlieva, and G. Ando. "Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates." Value in Health 16, no. 7 (2013): A455. https://doi.org/10.1016/j.jval.2013.08.764.

MLA (9th ed.) Citation

Labban, M., et al. "Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates." Value in Health, vol. 16, no. 7, 2013, p. A455, https://doi.org/10.1016/j.jval.2013.08.764.